Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01237938 · ClinicalTrials.gov registry record · NA

Effect of a Low Glycemic Index Diet on Breast Density

A NA study, sponsored by Roswell Park Cancer Institute.

Terminated
Registry status
NA
Development phase
46
Enrollment target

NCT01237938: Clinical Trial NA study, sponsored by Roswell Park Cancer Institute.

NCT01237938 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01237938, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.

TERMINATED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

This study is a Pilot Phase II cancer intervention trial of a low glycemic index diet to reduce mammographic density in women at high risk for breast cancer.

Primary Outcome

To Assess the feasibility of a randomized trial to achieve diet change and promote longterm adoption of a low glycemic index diet intervention among women at high risk for breast cancer (\> 50% of breast area occupied by radiological density)

Interventions

  • BEHAVIORAL Low Glycemic Diet

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2006-03
Phase NA
Roswell Park Cancer Institute

365 total trials

Why NCT01237938 stopped before completion

NCT01237938 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Low Glycemic Diet is the first listed.

NCT01237938 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01237938 about?

NCT01237938 is a clinical study titled "Effect of a Low Glycemic Index Diet on Breast Density". This study is a Pilot Phase II cancer intervention trial of a low glycemic index diet to reduce mammographic density in women at high risk for breast cancer.

What is the current status of trial NCT01237938?

This trial is currently terminated. It is a NA study. The enrollment target is 46 participants. The study started on 2006-03.

What interventions are being tested in trial NCT01237938?

The interventions under investigation include: Low Glycemic Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT01237938?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01237938's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01237938, the US trial registry maintained by the National Library of Medicine. NCT01237938 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.